The problem
At the recent conference on 'Clinical Biochemistry Nearer the Patient', organised by Marks and Alberti in Guildford,' the discussion on ion-selective electrodes (ISEs) illustrated the division between instrument manufacturers and the profession in their approach to this technology. The major cause of this problem lies in the confusion which results from differences between direct and indirect methods of measuring ·sodium and potassium. History has largely determined that these ions are usually measured by indirect methods using flame photometry or ISEs on pre diluted specimens. With these techniques sample dilution ensures that results are expressed as substance concentration (mmoVI of solution). Recent improvements in ISE technology have made it possible to measure sodium, potassium and other ions by direct potentiometry in their undiluted natural matrix. With this technique the electrochemical activity of the ion species in plasma water, rather than its molar concentration in whole plasma, is sensed. Different instrument manufacturers have used various means to interpret activity sensed by the electrode in terms of ion concentration. Not surprisingly therefore, instruments from different manufacturers rarely give the same value for ion concentration in patients' samples. In consequence it is difficult for clinical chemists to avoid the feeling that results reported by direct ISEs have little sound scientific basis and that the 'true' value is being deliberately and expediently obscured by the manufacturer. There have been two reactions to this. A proportion of the profession has avoided the problem by continuing to use dilution methods exclusively. Others have appreciated the advantages of direct reading methods and in introducing them have been prepared to accept the difficulties of comparing the values they report with those of the dilution methods used alongside them. Neither response is entirely appropriate and, in order to develop the most satisfactory practical approach, it is necessary to understand the scientific basis on which direct ISE measurements depend.
The theory
Ion selective electrodes sense electrochemical activity and not concentration. These two are related by the equation:
The activity coefficient expresses the extent to which ions in solution deviate from 'ideal' Nerstian behaviour. At infinite dilution, y is unity and activity is numerically equal to concentration. In samples at physiological ionic strength, the relatively close proximity of ions prevents each from exerting its full effect. Thus the activity coefficient for sodium ions decreases from unity at a concentration of about 1<r4 mmol/l to about 0·75 in normal plasma. It is reasonable to suppose that the physiological effects of ions in their natural biological environment relate more to their ionic activity than to their concentration. This concept has long been accepted with pH which is an expression of hydrogen ion activity. From the equation, the activities of sodium and potassium in normal plasma can be calculated to be about 105 mmoVl and 3 rnmol/l at concentrations of 140 rnmol/l and 4 mrnol/l respectively. However, the activity coefficient of 0·75 (used to calculate the activity of 105 mmoVl) is an approximation and cannot at present be accurately known in a given sample.
Most instrument manufacturers calibrate with solutions containing 140 mrnol/l sodium and 4 rnmol/l potassium. However, differences in their choice of buffer lead to differing ion activities in their calibrants. Furthermore, instruments differ in the composition and design of their reference electrodes, which influence the way in which activities are sensed, particularly in complex solutions. Many of these differences in approach are imposed by commercial and patent pressure and cannot be eliminated by a general edict, from whatever authority. Thus absolutely accurate measurement of activity is impossible even in relatively simple solutions, as demonstrated by the anomalous results which will be obtained if the calibrants of one instrument are measured on another manufacturer's instrument. Given these difficulties with simple solutions, it can be seen that there are many more problems in accurately determining ion activities in plasma, where protein influences are strong but quantitatively indeterminate. Qualitatively they include solvation effects and analyte ion binding and are likely to be pH-dependent. Manufacturers have thus had to adopt a compromise based on the erroneous assumption that the activity of the ion in their calibrant is the same as that in normal plasma. It follows that it is currently impossible to report 'true' ion activities in plasma, just as it is impossible to report 'true' enzyme activities: both are methoddependent.
Clinical practice
Despite these complications, direct ISEs have a number of important advantages over indirect methods in the clinical environment, notably speed, small sample volume requirements and the easier use of whole blood specimens. More importantly, they provide results which are probably of greater pathophysiological relevance than those of indirect methods. The hoary old chestnut of pseudohyponatraemia in the presence of hyperproteinaemia or hyperlipidaemia should be well known to clinical chemists, but may potentially trip up the unwary clinician. This relatively unusual misinterpretation of plasma sodium concentration when measured by indirect methods may lead to inappropriate and possibly life-threatening treatment of the patient. It is particularly liable to occur when accessory measurement of protein is not available, for instance out of normal working hours, or when the significance of gross lipaemia is not appreciated. The use of direct ISEs obviates this problem.
A solution?
The advantages of direct ISEs are rapidly leading to their introduction into emergency laboratories and intensive-care areas. However, it is clearly unrealistic to expect them to replace indirect methods, in which there is considerable financial investment, in the short term. The two methods will need to coexist for some time and a strategy must be evolved to allow this. If direct ISE values were expressed in terms of activity, the reference ranges for sodium and potassium would be approximately 100-115 mmol/l and 2·6-3·9 mrnol/l respectively-i-clearly a major difference from the conventional concentration ranges. It makes no practical sense to employ an activity range in the emergency laboratory and a concentration range in the routine laboratory; the potential for disaster is obvious. In the long term the most scientifically valid solution would involve the difficult task of successfully promoting the concept that plasma ions can be expressed in two ways-as activity or concentration, with different reference ranges. However, our present inability to measure activity accurately makes it difficult to justify this approach.
It has been suggested that it would be more desirable to express results of direct ISE measurements as molality (mmoVkg plasma water) to reflect the indifference of direct ISEs to volume displacement effects. Doing this, however, in,volves the addition offurther inaccurate assumptions, such as the mass concentration in plasma of water accessible to ions. Despite its superficial appeal, this suggestion therefore adds little scientifically and would contribute yet another set of reference ranges to the data pollution.
If, therefore, it is concluded that the only immediate practical solution is to use common reference ranges for direct and indirect methods, this could be done by adjusting the ISE to read the same as the flame photometer (i.e., substance concentration) on average plasma samples with normal protein and lipid concentrations. There will still be differences between methods for lipaemic or hyperproteinaemic plasma, for which the direct ISE result will be acknowledged to be more physiologically relevant. Except for these types of specimen, direct and indirect methods should give the same results for sodium and potassium over the range of concentrations encountered in hospital practice, with no interference from any other substances present (e.g., lithium or heparin) in concentrations which may reasonably be expected in patients' specimens. Results obtained by direct ISEs on whole blood should not differ from those in its separated plasma.
If the professions concerned agree on such an approach, manufacturers can consider means of implementation. Otherwise, the present wide and confusing differences will persist, to the detriment of all. The closest possible collaboration between the profession and manufacturers is required to achieve such agreement, a task which is made difficult by the large number and wide international distribution of the manufacturers in Europe, the USA and Japan.
As many clinical chemists will be aware from IFCC News.? this question has been considered by the IFCC Expert Panel on pH and Blood Gases, which has recently set up European and American Working Groups to consider the problems in detail. These Groups include clinicians, clinical chemists, physical chemists and New ways with old ions 77 manufacturers, and provide the best type of forum for reaching the required international consensus. There is no intention to sacrifice a sound scientific basis in reaching a workable solution. While accurate ion-activity measurement must remain the goal, this is not currently possible for sodium or potassium. We must do the best we can until direct ISEs replace indirect methods, and we can be confident that the ion activities we report are accurate.
